REQUEST A DEMO
Total
USD $0.00
Search more companies

Minapharm Pharmaceuticals S.A.E. (Egypt)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Minapharm Pharmaceuticals S.A.E. Profile Updated: February 06, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Minapharm Pharmaceuticals is an Egyptian shareholding company, incorporated in 1986. The company's core activity is the production of medicines for some main therapeutic group. Minapharm distributes its products mainly in Egypt.

Legal Address
2 El Bardessi St., Off Asmaa Fahmi St,Elgolf Behind El Rekaba Eledarya,Masr Elgdeda
Cairo; Greater Cairo;

Contact Details: Purchase the Minapharm Pharmaceuticals S.A.E. report to view the information.

Website: http://www.minapharm.com

Basic Information
Total Employees:
Purchase the Minapharm Pharmaceuticals S.A.E. report to view the information.
Outstanding Shares:
Purchase the Minapharm Pharmaceuticals S.A.E. report to view the information.
Registered Capital:
Purchase the Minapharm Pharmaceuticals S.A.E. report to view the information.
Financial Auditors:
Purchase the Minapharm Pharmaceuticals S.A.E. report to view the information.
Ratings:
Purchase the Minapharm Pharmaceuticals S.A.E. report to view the information.
Incorporation Date:
1986
Key Executives
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
10.38%
Subsidiaries
Minapharm Probiogen Sae
Company Performance
Financial values in the chart are available after Minapharm Pharmaceuticals S.A.E. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
27.29%
Total operating revenue
27.47%
Operating profit (EBIT)
40.86%
EBITDA
34.41%
Net Profit (Loss) for the Period
52.85%
Total assets
17.88%
Total equity
21.95%
Operating Profit Margin (ROS)
2.27%
Net Profit Margin
2.64%
Return on Equity (ROE)
4.94%
Debt to Equity Ratio
0.52%
Quick Ratio
0.19%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?